首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Bioinorganic Chemistry Special Feature: A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition
【2h】

Bioinorganic Chemistry Special Feature: A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition

机译:生物无机化学的特殊功能:用于高亲和力DNA碱基对错配识别的铑(III)配合物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A rhodium(III) complex, rac-[Rh(bpy)2phzi]3+ (bpy, 2,2′-bipyridine; phzi, benzo[a]phenazine-5,6-quinone diimine) has been designed as a sterically demanding intercalator targeted to destabilized mismatched sites in double-helical DNA. The complex is readily synthesized by condensation of the phenazine quinone with the corresponding diammine complex. Upon photoactivation, the complex promotes direct strand scission at single-base mismatch sites within the DNA duplex. As with the parent mismatch-specific reagent, [Rh(bpy)2(chrysi)]3+ [chrysene-5,6-quinone diimine (chrysi)], mismatch selectivity depends on the helix destabilization associated with mispairing. Unlike the parent chrysi complex, the phzi analogue binds and cleaves with high affinity and efficiency. The specific binding constants for CA, CC, and CT mismatches within a 31-mer oligonucleotide duplex are 0.3, 1, and 6 × 107 M−1, respectively; site-specific photocleavage is evident at nanomolar concentrations. Moreover, the specificity, defined as the ratio in binding affinities for mispaired vs. well paired sites, is maintained. The increase in affinity is attributed to greater stability in the mismatched site associated with stacking by the heterocyclic aromatic ligand. The high-affinity complex is also applied in the differential cleavage of DNA obtained from cell lines deficient in mismatch repair vs. those proficient in mismatch repair. Agreement is found between photocleavage by the mismatch-specific probes and deficiency in mismatch repair. This mismatch-specific targeting, therefore, offers a potential strategy for new chemotherapeutic design.
机译:铑(III)配合物rac- [Rh(bpy)2phzi] 3 + (bpy,2,2'-联吡啶; phzi,苯并[a]吩嗪-5,6-醌二亚胺)已被设计为对双螺旋DNA中不稳定的错配位点有空间要求的嵌入剂。通过吩嗪醌与相应的二胺配合物的缩合可以容易地合成该配合物。光活化后,复合物促进DNA双链体中单碱基错配位点的直接链断裂。与母体错配特异性试剂[Rh(bpy)2(chrysi)] 3 + [chrysene-5,6-quinone diimine(chrysi)]一样,错配选择性取决于相关的螺旋去稳定作用配对错误。不同于亲代的chrysi复合物,phzi类似物以高亲和力和效率结合并裂解。 31聚体寡核苷酸双链体中CA,CC和CT错配的特异性结合常数分别为0.3、1和6×10 7 M -1 。在纳摩尔浓度下,位点特异性光裂解是明显的。此外,保留了特异性,定义为错配位与好配对位的结合亲和力之比。亲和力的增加归因于与杂环芳族配体的堆积相关的错配位点的更大稳定性。高亲和力复合物也可用于从错配修复缺陷的细胞系与熟练进行错配修复的细胞系获得的DNA的差异切割中。在失配特异性探针的光裂解与失配修复缺陷之间达成了一致。因此,这种错配特异性靶向为新的化疗设计提供了潜在的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号